GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omeros Corp (LTS:0KBU) » Definitions » Future 3-5Y Total Revenue Growth Rate

Omeros (LTS:0KBU) Future 3-5Y Total Revenue Growth Rate : N/A (As of Jan. 19, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Omeros Future 3-5Y Total Revenue Growth Rate?

Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Omeros's Future 3-5Y Total Revenue Growth Rate is N/A.


Competitive Comparison of Omeros's Future 3-5Y Total Revenue Growth Rate

For the Biotechnology subindustry, Omeros's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omeros's Future 3-5Y Total Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omeros's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Omeros's Future 3-5Y Total Revenue Growth Rate falls into.



Omeros  (LTS:0KBU) Future 3-5Y Total Revenue Growth Rate Explanation

Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Omeros Future 3-5Y Total Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Omeros's Future 3-5Y Total Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Omeros Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omeros Corp (LTS:0KBU) » Definitions » Future 3-5Y Total Revenue Growth Rate
Traded in Other Exchanges
Address
201 Elliott Avenue West, Seattle, WA, USA, 98119
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Omeros Headlines

No Headlines